Provided are a herbicidal composition having excellent control effect on weeds and a method for controlling weeds. The herbicidal composition comprising one or more PPO-inhibiting herbicides selected from the group consisting of flumioxazin, flumiclorac-pentyl, lactofen, carfentrazone-ethyl, sulfentrazone, tiafenacil, trifludimoxazin, and a compound represented by the following formula (I):

##STR00001##

wherein X represents CH or a nitrogen atom, and Z represents CH or a nitrogen atom, and glufosinate or a salt thereof, wherein a weight ratio of the PPO-inhibiting herbicide to the glufosinate or a salt thereof is 1:150 to 1:700.

Provided are a herbicidal composition having excellent control effect on weeds and a method for controlling weeds. The herbicidal composition comprising one or more PPO-inhibiting herbicides selected from the group consisting of flumioxazin, flumiclorac-pentyl, lactofen, carfentrazone-ethyl, sulfentrazone, tiafenacil, trifludimoxazin, and a compound represented by the following formula (I):

##STR00001##

wherein X represents CH or a nitrogen atom, and Z represents CH or a nitrogen atom, and glufosinate or a salt thereof, wherein a weight ratio of the PPO-inhibiting herbicide to the glufosinate or a salt thereof is 1:150 to 1:700.

Disclosed is a formulation having at least two auxinic hormonal herbicides, normally used separately in applications to control a wide variety of broadleaf weeds, present in fields without cultivation, during chemical fallows, and in crops such as winter cereals, corn and sorghum, that together have a synergistic effect on weed control. This effect is even greater in the microemulsion formulation that includes at least the two active ingredients, if compared to the conventional tank mix, this greater efficiency being attributed to the chemical compatibility that exists in the “ready mix” achieved by the correct choice of emulsifiers to maintain active emulsion, physical compatibility that translates into greater biological efficacy. Preferably, the herbicidal composition has at least: (i) from 7.5% to 40% of 2,4-D in its acidic form; and (ii) from 1.2% to 35% of Dicamba in its acid formic as active ingredients, formulated together in a microemulsion type formulation.

Disclosed is a formulation having at least two auxinic hormonal herbicides, normally used separately in applications to control a wide variety of broadleaf weeds, present in fields without cultivation, during chemical fallows, and in crops such as winter cereals, corn and sorghum, that together have a synergistic effect on weed control. This effect is even greater in the microemulsion formulation that includes at least the two active ingredients, if compared to the conventional tank mix, this greater efficiency being attributed to the chemical compatibility that exists in the “ready mix” achieved by the correct choice of emulsifiers to maintain active emulsion, physical compatibility that translates into greater biological efficacy. Preferably, the herbicidal composition has at least: (i) from 7.5% to 40% of 2,4-D in its acidic form; and (ii) from 1.2% to 35% of Dicamba in its acid formic as active ingredients, formulated together in a microemulsion type formulation.

This invention relates in part to soybean event pDAB8264.44.06.1 and includes a novel expression cassettes and transgenic inserts comprising multiple traits conferring resistance to glyphosate, aryloxyalkanoate, and glufosinate herbicides. This invention also relates in part to methods of controlling resistant weeds, plant breeding and herbicide tolerant plants. In some embodiments, the event sequence can be “stacked” with other traits, including, for example, other herbicide tolerance gene(s) and/or insect-inhibitory proteins. This invention further relates in part to endpoint TaqMan PCR assays for the detection of Event pDAB8264.44.06.1 in soybeans and related plant material. Some embodiments can perform high throughput zygosity analysis of plant material and other embodiments can be used to uniquely identify the zygosity of and breed soybean lines comprising the event of the subject invention. Kits and conditions useful in conducting these assays are also provided.

This invention relates in part to soybean event pDAB8264.44.06.1 and includes a novel expression cassettes and transgenic inserts comprising multiple traits conferring resistance to glyphosate, aryloxyalkanoate, and glufosinate herbicides. This invention also relates in part to methods of controlling resistant weeds, plant breeding and herbicide tolerant plants. In some embodiments, the event sequence can be “stacked” with other traits, including, for example, other herbicide tolerance gene(s) and/or insect-inhibitory proteins. This invention further relates in part to endpoint TaqMan PCR assays for the detection of Event pDAB8264.44.06.1 in soybeans and related plant material. Some embodiments can perform high throughput zygosity analysis of plant material and other embodiments can be used to uniquely identify the zygosity of and breed soybean lines comprising the event of the subject invention. Kits and conditions useful in conducting these assays are also provided.

The present invention relates to methods for producing nanoparticle and microparticle powders of a biologically active material which have improved powder handling properties making the powders suitable for commercial use using dry milling processes as well as compositions comprising such materials, medicaments produced using said biologically active materials in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of said biologically active materials administered by way of said medicaments.

The present invention relates to methods for producing nanoparticle and microparticle powders of a biologically active material which have improved powder handling properties making the powders suitable for commercial use using dry milling processes as well as compositions comprising such materials, medicaments produced using said biologically active materials in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of said biologically active materials administered by way of said medicaments.

A formulation includes a water-soluble salt of 2,4-dichlorophenoxyacetic acid; and 2.5 wt % to 10 wt % of a carrier fluid based on a total weight of the formulation. The carrier fluid includes 0.5 wt % to 5 wt % of solvent based on a total weight of the formulation, wherein the solvent is selected from the group consisting of ethylene glycol mono butyl ether, diethylene glycol monobutyl ether, dipropylene glycol monomethyl ether and combinations thereof; and 0.5 wt % to 5 wt % of a polyalkylene glycol monoalkyl ether surfactant based on a total weight of the formulation.

A formulation includes a water-soluble salt of 2,4-dichlorophenoxyacetic acid; and 2.5 wt % to 10 wt % of a carrier fluid based on a total weight of the formulation. The carrier fluid includes 0.5 wt % to 5 wt % of solvent based on a total weight of the formulation, wherein the solvent is selected from the group consisting of ethylene glycol mono butyl ether, diethylene glycol monobutyl ether, dipropylene glycol monomethyl ether and combinations thereof; and 0.5 wt % to 5 wt % of a polyalkylene glycol monoalkyl ether surfactant based on a total weight of the formulation.